Chesney PJ: Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis. 1989, 11 (Suppl 1): S1-S7.
Article
PubMed
Google Scholar
Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, Harwell J, Lefkowitz LK, Makintubee S, Cundiff DR, Sitze S, the Toxic Shock Syndrome Study Group: Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis. 1989, 11 (Suppl 1): S28-S34.
Article
PubMed
Google Scholar
Todd JK, Wisenthal AM, Ressman M, Caston SA, Hopkins RS: Toxic shock syndrome II. Estimated occurrence in Colorado as influenced by case ascertainment methods. Am J Epidemiol. 1985, 122: 857-867.
CAS
PubMed
Google Scholar
Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, Mohammedi I, Etienne J: One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis. 2008, 27 (1): 37-43. 10.1007/s10096-007-0405-2.
Article
CAS
PubMed
Google Scholar
Garbe PL, Arko RL, Reingold AL, Graves LM, Hayes PS, Hightower AW, Chandler FW, Broome CV: Staphylococcus aureus isolates form patients with non-menstrual toxic shock syndrome. Evidence for additional toxins. JAMA. 1985, 253: 2538-10.1001/jama.253.17.2538.
Article
CAS
PubMed
Google Scholar
Czerwinski BS: Variation in feminine hygiene practices as a function of age. J Obstet Gynecol Neonatal Nurs. 2000, 29: 625-33. 10.1111/j.1552-6909.2000.tb02076.x.
Article
CAS
PubMed
Google Scholar
Nelson E, Jordan M: Sensitive Export: Seeking New Markets for Tampons, P&G Faces Cultural Barriers. The Wall Street Journal. 2000, A1-
Google Scholar
Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Lee AC, Chesney PJ, Davis JP, Vergeront JM, Wand PJ: An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med. 1982, 96: 969-971.
Article
CAS
PubMed
Google Scholar
Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD: Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981, 143: 509-516.
Article
CAS
PubMed
Google Scholar
Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M: Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol. 2000, 30: 3247-3255. 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med. 2002, 8: 1398-1404. 10.1038/nm800.
Article
CAS
PubMed
Google Scholar
Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, Andersson U, Kotb M: Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996, 156: 3057-3064.
CAS
PubMed
Google Scholar
Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, Schwartz B, Kotb M: Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun. 1999, 67: 1871-1877.
CAS
PubMed
PubMed Central
Google Scholar
Parsonnet J, Hansmann MA, Delaney ML, Modern PA, DuBois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB: Prevalence of toxic shock syndrome toxin-1 producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Micro. 2005, 43: 4628-4634. 10.1128/JCM.43.9.4628-4634.2005.
Article
CAS
Google Scholar
Parsonnet J, Sullivan C, Modern P, Wissemann K: Risk factors for TSS among European women: vaginal colonization with S. aureus and antibody to TSST-1. Proceedings of the European conference on toxic shock syndrome. Edited by: Arbuthnott J, Furman B. 1997, London, The Royal Society of Medicine Press, Ltd, 72-
Google Scholar
Adesium AA, Singh D, Guness RI: Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad. Zentralbl Bakteriol. 1994, 280: 371-381.
Article
Google Scholar
Chow AW, Bartlett KH, Percival-Smith R, Morrison BJ: Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J Infect Dis. 1984, 150: 80-84.
Article
CAS
PubMed
Google Scholar
Linnemann CC, Staneck JL, Hornstein S, Barden TP, Rauh JL, Boneventre PF, Buncher CR, Benting A: The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med. 1982, 96: 940-944.
Article
PubMed
Google Scholar
Yarwood JM, Schlievert PM: Oxygen and carbon dioxide: Regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol. 2000, 38 (5): 1797-1803.
CAS
PubMed
PubMed Central
Google Scholar
Sarafian SK, Morse SA: Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J Med Microbio. 1987, 24: 75-81. 10.1099/00222615-24-1-75.
Article
CAS
Google Scholar
Taylor D, Holland KT: Effect of dilution rate and Mg+2 limitation on toxic shock syndrome toxin-1 production by Staphylococcus aureus grown in defined continuous culture. J Gen Microbiol. 1988, 134: 719-723.
CAS
PubMed
Google Scholar
Wong AC, Bergdoll MS: Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect Immun. 1990, 58: 1026-1029.
CAS
PubMed
PubMed Central
Google Scholar
Davis CC, Kremer MJ, Schlievert PM, Squier CA: Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution and tissue damage. Am J Obstet Gynecol. 2003, 189: 1785-1791. 10.1016/S0002-9378(03)00873-1.
Article
CAS
PubMed
Google Scholar
Bonventre PF, Thompson MR, Adinolfi LE, Gillis ZA, Parsonnet J: Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun. 1998, 56 (1): 135-41.
Google Scholar
Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS: Prevalence of serum antibody to staphyloccocal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis. 1983, 148: 692-698.
Article
CAS
PubMed
Google Scholar
Jacobson JA, Kasworm EM, Crass BA, Bergdoll MS: Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah. J Infect Dis. 1986, 153: 356-359.
Article
CAS
PubMed
Google Scholar
VandenBergh MFQ, Yzerman EPF, van Belkum A, Boelens HAM, Sijmons M, Verbrugh HA: Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Micro. 1999, 37 (10): 3133-3140.
CAS
Google Scholar
Peacock SJ, Justice A, Griffiths D, de Silva GDI, Kantzanou MN, Crook D, Sleeman K, Day NPJ: Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Micro. 2003, 41 (12): 5718-5725. 10.1128/JCM.41.12.5718-5725.2003.
Article
Google Scholar
Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore G, Tenover FC: Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006, 193: 172-179. 10.1086/499632.
Article
CAS
PubMed
Google Scholar
Nouwen J, Boelens H, van Belkum A, Verbrugh H: Human factor in Staphylococcus aureus nasal carriage. Infect Immun. 2004, 72 (11): 6685-6688. 10.1128/IAI.72.11.6685-6688.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nouwen JL, Ott A, Kluytmans-Vandenbergh MFQ, Boelens HAM, Hofman A, van Belkum A, Verbrugh H: Predicting the Staphylococcus aureus nasal carrier state: derviation and validation of a "culture rule". Clin Infect Dis. 2004, 39: 806-811. 10.1086/423376.
Article
PubMed
Google Scholar
Kansal R, Davis C, Hansmann M, Seymour J, Parsonnet J, Modern P, Gilbert S, Kotb M: Structural and Functional Properties of Antibodies to the Superantigen TSST-1 and Their Relationship to Menstrual Toxic Shock Syndrome. J Clin Immunol. 2007, 27 (3): 327-338. 10.1007/s10875-007-9072-4.
Article
CAS
PubMed
Google Scholar
Tavares D, Sa-Leo R, Miragaia M, Lencastre H: Large screening of CA-MRSA among Staphylococcus aureus colonizing healthy young children living in two areas (urban and rural) of Portugal. BMC Infectious Diseases. 2010, 110-10.1186/1471-2334-10-110.
Google Scholar
Parsonnet J, Mills JT, Gillis ZA, Pier GB: Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin-1. J Clin Microbiol. 1985, 22: 26-31.
CAS
PubMed
PubMed Central
Google Scholar
Johnson WM, Tyler SD: PCR Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin-1 in Staphylococcus aureus. Diagnostic molecular microbiology principles and applications. Edited by: Persing DM, Smith TF, Tenover FC, White TJ. 1993, Rochester MN, American Society for Microbiology, 294-299.
Google Scholar
Nilsson P, Ripa T: Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares. J Clin Micro. 2006, 44 (9): 3334-3339. 10.1128/JCM.00880-06.
Article
CAS
Google Scholar
Shuter V, Hatcher B, Lowy FD: Staphylococcus aureus binding to human nasal mucin. Infect Immun. 1996, 64 (1): 310-318.
CAS
PubMed
PubMed Central
Google Scholar
Walsh EJ, O'Brien LM, Liang X, Hooks M, Foster TJ: Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. Journal of Chemistry. 2004, 279 (49): 50691-50699.
CAS
Google Scholar
van den Akker ELT, Nouwen JL, Melles DC, van Rossum EFC, Koper JW, Uitterlinden AG, Hofman A, Verbrugh HA, Pols HA, Lamberts SWJ, Van Belkum A: Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis. 2006, 194: 814-818. 10.1086/506367.
Article
CAS
PubMed
Google Scholar
Vesterlund S, Karp M, Salminen S, Ouwehand AC: Staphylococcus aureus adheres to human intenstinal mucus but can be displaced by certain lactic acid bacteria. Microbiology. 2006, 152: 1819-1826. 10.1099/mic.0.28522-0.
Article
CAS
PubMed
Google Scholar
Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE: Metagenomic analysis of the human distal gut microbiome. Science. 2006, 312: 1355-1359. 10.1126/science.1124234.
Article
CAS
PubMed
PubMed Central
Google Scholar
van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Werthiem HFL: Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis. 2009, 199: 1820-1826. 10.1086/599119.
Article
PubMed
Google Scholar
Thomas D, Dauwalder O, Brun V, Badiou C, Ferry T, Etienne J, Vandenesch F, Lina G: Staphylococcus aureus Superantigens Elicit Redundant and Extensive Human Vß Patterns. Infect Immun. 2009, 77 (5): 2043-2050. 10.1128/IAI.01388-08.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Kurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE: An immunogenetics and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med. 2002, 8 (12): 1398-1404. 10.1038/nm800.
Article
CAS
PubMed
Google Scholar